Analyses / KLAC
Chip-equipment play riding AI/process node momentum; valuation stretched but quality defensible.
A free account reveals KLAC's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Market-leading position in wafer inspection & metrology for advanced nodes (7nm/5nm/3nm). AI capex cycle sustains semi equipment demand. 62% gross margin, 41.8% op margin, 35.6% net margin show durable pricing power. 5Y EPS growth 22.3% & revenue growth 14.4% outpace sector. Beta 1.45 captures upside leverage to semi strength. Dividend yield 1.04% + solid cash generation supports buyback & shareholder returns.
▼ Bear Case
P/E 50.2x & forward P/E 50.2x are elevated vs historical; P/S 17.9x & EV/EBITDA 41.1x suggest full valuation on growth. Price-to-FCF 64.4x hints at thin FCF yield. 52-week pullback from $307 to $185 (−40%) shows vulnerability to cycle concerns. Insider selling (69 sells vs 32 buys, −4.5K net shares) hints at caution among insiders. Cyclical semi demand risk if AI capex moderates or CapEx spending normalizes.
Valuation
OVERVALUED on static multiples; FAIR on forward growth trajectory. — score 62/100
P/E 50.2x and EV/EBITDA 41.1x are steep for a mature semi-equipment player, even with 23% 5Y EPS growth. However, if current AI capex sustains and KLAC expands addressable market (advanced process nodes, chiplet metrology, power delivery), forward multiples may compress to 35–40x by 2025E, justifying current levels. Margin profile (62% gross, 41.8% op, 35.6% net) is industry-leading and supports pricing resilience. Key risk: cyclical reset if capex normalizes.
Technical Levels
Support · $172.94 (Prior close; immediate support) · $165.00 (Stop-loss; psychological support) · $155.00 (2–3-month moving average support (est.)) · $135.00 (50% retracement of 52-week range (87.83–307.37))
Resistance · $187.36 (Today's high; session resistance) · $195.00 (Psychological level; prior 2–3 week high) · $210.00 (Target; 200-day MA zone (est.)) · $230.00 (Bull-case target; 38.2% retracement of 52W range) · $307.00 (52-week high; structural resistance)
Financial Health
Score 82/100. Strong liquidity position (current ratio 2.88x indicates solid working-capital buffer). Conservative payout ratio (21.9%) allows reinvestment/buyback flexibility. Debt metrics unavailable; recommend checking latest 10-Q for net debt/EBITDA levels. No red flags on balance-sheet health apparent from available data.
Catalysts
| Next quarterly earnings (Q3 or Q4 FY2025 likely) | ~6–12 weeks | high |
| FY2025 guidance update; AI capex commentary from large customers (TSMC, Samsung, Intel) | Earnings call; near-term | high |
| Advanced-node process technology announcements (3nm, 2nm node adoption ramp) | Ongoing; next major milestones 2H2025 | high |
| Industry conference speaking engagements (SEMICON, Morgan Stanley Tech Conference, etc.) | Seasonal; next likely Aug–Sept 2025 | medium |
| Geopolitical news (US-China export controls, Taiwan tensions affecting capex) | Unpredictable | high |
Risk Flags
See KLAC's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock KLAC free →Recent News
- SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For September 2026SeekingAlpha
- Two Chip-Equipment Stocks Just Crushed Nvidia. Is the AI Rally Broadening?Yahoo
- Micron and Western Digital Shares Skyrocket, What You Need To KnowYahoo
- FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To KnowYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full KLAC analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
KLAC FAQ
Is KLAC a buy right now?
KLA Corp's current read is a Growth / Quality setup with 72 confidence over a 3–6 months horizon. Valuation: OVERVALUED on static multiples; FAIR on forward growth trajectory.. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is KLAC overvalued?
OVERVALUED on static multiples; FAIR on forward growth trajectory. (valuation score 62/100). P/E 50.2x and EV/EBITDA 41.1x are steep for a mature semi-equipment player, even with 23% 5Y EPS growth. However, if current AI capex sustains and KLAC expands addressable market (advanced process nodes, chiplet metrology, power delivery), forward multiples may compress to 35–40x by 2025E, justifying current levels. Margin profile (62% gross, 41.8% op, 35.6% net) is industry-leading and supports pricing resilience. Key risk: cyclical reset if capex normalizes.
What are the risks of buying KLAC?
P/E 50.2x & forward P/E 50.2x are elevated vs historical; P/S 17.9x & EV/EBITDA 41.1x suggest full valuation on growth. Price-to-FCF 64.4x hints at thin FCF yield. 52-week pullback from $307 to $185 (−40%) shows vulnerability to cycle concerns. Insider selling (69 sells vs 32 buys, −4.5K net shares) hints at caution among insiders. Cyclical semi demand risk if AI capex moderates or CapEx spending normalizes.